Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: Results from the SWiTCH trial

82Citations
Citations of this article
170Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) trial compared standard (transfusions/chelation) to alternative (hydroxyurea/ phlebotomy) treatment to prevent recurrent stroke and manageiron overload in children chronically transfused over 7 years before enrollment. Standardized brain magnetic resonance imaging/magnetic resonance angiography (MRA) and transcranial Doppler (TCD) exams were performed at entry and exit, with a central blinded review. A novel MRA vasculopathy grading scale demonstrated frequent severe baseline left/right vessel stenosis (53%/41% Grade 4); 31% had no vessel stenosis on either side. Baseline parenchymal injury was prevalent (85%/79% subcortical, 53%/37%cortical, 50%/35%subcortical and cortical).Most children had low or uninterpretable baseline middle cerebral artery TCD velocities, which were associated with worse stenoses (incidence risk ratio [IRR] = 5.1, P ≤ .0001 and IRR = 4.1, P

Cite

CITATION STYLE

APA

Helton, K. J., Adams, R. J., Kesler, K. L., Lockhart, A., Aygun, B., Driscoll, C., … Ware, R. E. (2014). Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: Results from the SWiTCH trial. Blood, 124(6), 891–898. https://doi.org/10.1182/blood-2013-12-545186

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free